A Multiple Ascending Dose, Phase 1b Study of YH35324 in Atopic Healthy Subjects or Subjects With Allergic Diseases

Clinical trial NCT05564221 · COMPLETED

Trial details

NCT number: NCT05564221
Sponsor: Yuhan Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Atopic Healthy Subjects Adult Subjects With Allergic Diseases

Start date: 2022-11-01
Primary completion: 2024-11-28
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.